PharmaCyte Biotech Inc (PMCB)

[ace1234]

However keep in mind, that while this technology is extremely promising, there are competitors out there with similar technology.

A company called ViaCyte... eerily/strangely similar to PharmaCyte is already in clinicals for type 1 and type 2 diabetes using cell encapsulation. They had their IND meeting in 2014 and are currently in phase 1/2.

Management is currently focusing on pancreatic cancer because there is an urgent unmet need. Considering that we have the best of the best on board, I would say PMCB has a high likelihood of fulfilling that need.

Once that is out of the way, diabetes will sure follow, but it's hard to say if another encapsulation technology will have already entered the market.

I know when you look at a stock you have to think rationally. There is always risk involved... and competition, but I believe PMCB has got what it takes.